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Abstract
Background: Roundabouts are axon guidance molecules that have recently been identified to play
a role in vascular guidance as well. In this study, we have investigated gene knockdown analysis of
endothelial Robos, in particular roundabout 4 (robo4), the predominant Robo in endothelial cells
using small interfering RNA technology in vitro.
Results: Robo1 and Robo4 knockdown cells display distinct activity in endothelial cell migration
assay. The knockdown of robo4 abrogated the chemotactic response of endothelial cells to serum
but enhanced a chemokinetic response to Slit2, while robo1 knockdown cells do not display
chemotactic response to serum or VEGF. Robo4 knockdown endothelial cells unexpectedly show
up regulation of Rho GTPases. Zebrafish Robo4 rescues both Rho GTPase homeostasis and serum
reduced chemotaxis in robo4 knockdown cells. Robo1 and Robo4 interact and share molecules
such as Slit2, Mena and Vilse, a Cdc42-GAP. In addition, this study mechanistically implicates IRSp53
in the signaling nexus between activated Cdc42 and Mena, both of which have previously been
shown to be involved with Robo4 signaling in endothelial cells.
Conclusion: This study identifies specific components of the Robo signaling apparatus that work
together to guide directional migration of endothelial cells.
Background
Major classes of axon guidance molecules include the
Netrins, Semaphorins, Ephrins and Slit ligands, which
interact with their cognate family of receptors to orches-
trate stereotypical nerve patterns in a developing verte-
brate embryo [1]. Each family has at least one member
that plays a functional role in vascular development. Our
study focuses on the Roundabout (Robo) family of axon
guidance genes [2]. Robos are cell surface transmembrane
receptors that have been identified in most species to
mediate repulsion-guidance mechanisms in axons [3].
Four robo receptor genes (robo1-4) have been identified in
mammals, and their function vary widely depending on
the tissue where they are expressed [4]. Robo4, the fourth
member of the Robo family is expressed in both the neu-
ral and vascular systems [5,6]. Robo4 knockdown
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zebrafish embryos display intersomitic vessel (ISVs)
sprouting defects [5]. More recently, robo4AP/AP knockout
mice show defects in vascular integrity that exacerbates
pathological conditions associated with vascular leakage
[7].
Robo1 and Robo4 are the two endothelial relevant Robos.
Robo1 has been functionally implicated in the vascula-
ture; in the context of tumor growth [8]. Robo1 and
Robo4 share similar domains in both extracellular and
intracellular cytoplasmic regions, but they differ widely in
the number and spatial organization of these domains
[9]. Robo1 contains five-immunoglobulin (IgG) and
three-fibronectin domains compared to three and two
respectively for zebrafish Robo4 [9]. Human Robo4 dif-
fers slightly from zebrafish Robo4 in that it only contains
two IgG and two fibronectin domains [10]. In the intrac-
ellular region, Robo1 and Robo4 share two of the four
conserved cytoplasmic (CC) motifs CC0 and CC2. Robos
are known to homo- and hetero-dimerize, and dimeriza-
tion is responsible for mediating signal transduction in
neurons [11].
Slits are ligands for Robos [12-14]. Slit2 has been impli-
cated as the vascular-specific Slit and has been studied
extensively [10,15-17]. Contradictory results are reported
in the literature regarding Slit2's role in migration of
endothelial cells. Two groups report that Slit2 inhibits
migration of endothelial cells [6,18] and other groups
report that Slit2 mediates positive stimulus on endothelial
cells [8,19]. Axon guidance molecules are well known to
show such dual function [1]. For example, Slits were orig-
inally identified as attractants of sensory axons [13] and
were later identified as repellents for Robo+ axons [12,20].
To date, the functional output of Robos in endothelial
cells is unresolved [10]. Some reports indicate that Slit2
binds to Robo1 in endothelial cells and promotes migra-
tion of these cells [8,19]. However, in neurons, Slit-Robo1
interaction primarily mediates repulsive signals [12,21].
In the case of Robo4, the Slit2-Robo4 interaction is impli-
cated to inhibit migration of endothelial cells in vitro
[6,18]. We have demonstrated that Robo4 also induces
positive signal in endothelial cells and have implicated
attraction mechanisms [22]. Interestingly, soluble Robo4
shows anti-angiogenic effects in vitro supporting for this
possibility [23].
To facilitate clarity with Robos' function in endothelial
cells in vitro, we have initiated a loss-of-function study of
Robos' in vitro. To investigate the loss of function pheno-
type for robo1  and  robo4  in vitro, we have used Dicer
siRNA technology to knock down endogenous robo tran-
scripts in endothelial cells. Robo1 and Robo4 siRNAs spe-
cifically knocks down the respective Robo RNAs and
proteins in endothelial cells without affecting the other.
Robo4  siRNA knockdown endothelial cells did not
respond to serum but Robo1 siRNA knockdown cells do.
Slit2 binds to endothelial cells expressing both Robos but
does not bind to robo4  knockdown endothelial cells.
Interestingly,  robo4  siRNA cells display pro-migratory
response to Slit2 despite lack of binding of Slit2. This sug-
gests an alternative migration induced by Slit2 in the
absence of Robo4. Indeed, Slit2 displays chemotactic and
chemokinetic activity on robo4  knockdown endothelial
cells. Serum, on the other hand displays an exclusive
chemotactic activity on endothelial cells, which is abol-
ished in the absence of Robo4.
We had previously implicated Rho GTPases in Robo4-
induced migration signaling complex in endothelial cells
[22]. Here, we show that robo4 knockdown endothelial
cells contain increased Rho GTPase level, which is
restored by transfecting back zebrafish Robo4 suggesting
that any perturbation of Robo4 levels on endothelial cell
surface results in alteration of Rho GTPase homeostasis.
Importantly, this restoration is critical for endothelial cell
chemotaxis to serum. Slit2 treatment of endothelial cells
does not induce Rho GTPases suggesting that the mecha-
nism of Slit2 inhibition of endothelial cell migration is
Rho GTPase independent.
To explain the mechanism used by Robos for directing
endothelial cell migration, we have identified that Robo1
and Robo4 interact with each other and share several mol-
ecules. They both bind to Slit2, Mena [6,24] and Vilse, a
Cdc42-GAP. In addition, we implicate IRSp53, a Cdc42
target that is down-regulated in robo4 knockdown cells
that show no organized actin stress fiber arrangements.
Our data suggests that a complex of proteins (Cdc42-GTP,
IRSp53, Mena, Vilse) are part of a serum mediated Robo4
signaling axis that is responsible for directional migration
of endothelial cells.
Results and discussion
Robo4 siRNA specifically knocks down robo4 RNA and 
protein
We have first determined the expression levels of endothe-
lial Robos in human umbilical vein endothelial cells
(HUVECs). HUVECs show robust expression of robo4
when compared to robo1 (compare +RT lanes R4 with R1
in Fig. 1A). To knockdown endogenous robo4, we have uti-
lized the RNA interference technology [25] that relies on
Dicer enzyme, which converts double stranded RNA into
small interfering RNA (siRNA). We used the Dicer method
of generating pooled robo4 small interfering RNA (siRNA)
for a Robo4 region that was distinct from other Robos
since it is difficult to predict a priori which region of
Robo4 is optimal for targeting using siRNA. Increasing
concentrations (125–500 ng) of robo4 siRNA resulted in aBMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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dose dependant reduction of robo4  transcript (Fig. 1B,
lanes 8–13) with minimal change in robo1 (Fig. 1B, lanes
2–7) or actin  transcript levels (Fig. 1B, lanes 14–19).
Quantitative real time PCR analysis showed that robo4
transcript is down regulated by 80% when compared to
robo1  in  robo4  siRNA cells (Fig. 1C). Using the Dicer
method, we also designed robo1  siRNA and show that
robo1 siRNA selectively targets robo1 transcript (Fig. 1D,
compare lanes 1–2 to 3–4) with no effect on robo4 RNA
levels (Fig. 1D, robo4 gel).
To investigate whether robo4 RNA knockdown correlates
with protein levels, we generated a V5-tagged human
Robo4 fusion construct and co-transfected it with control
lacZ (Fig. 1E, lane 2) or robo4 siRNA (Fig. 1E, lane 3) in
293T cells. To unambiguously show that Robo4 protein
was down in robo4 siRNA cells, we took the transfected V5-
tagged approach. Protein lysates from robo4 siRNA sample
show lower amounts (Fig. 1E, lane 3, hRobo4 gel) of V5-
tagged protein when compared to control lacZ siRNA co-
transfected sample (Fig. 1E, lane 2, hRobo4 gel) or robo1
siRNA sample (Fig. 1E, lane 1, hRobo4 gel). Similarly
robo1 siRNA also shows selective knockdown of endog-
enous Robo1 protein (Fig. 1F, lanes 3 and 4, hRobo1 gel)
with no effect on transfected V5-tag Robo4 protein (Fig.
1E, lane 2) when compared to control lacZ siRNA cells
(Fig. 1F, lanes 1 and 2, hRobo1) or untransfected (UT)
cells (Fig. 1F, lane 5, hRobo1 gel). Taken together, these
results suggest that we have generated specific knockdown
reagents that can selectively target Robo1 and Robo4 in
endothelial cells.
Serum-mediated migration responses are selectively 
abrogated in robo4 knockdown endothelial cells
To investigate the robo4  knockdown phenotype in
endothelial cells, we have performed modified Boyden
chamber migration assays in the presence of serum in the
bottom chamber using endothelial cells transfected with
siRNA mediated knockdown of robo4 and robo1 Figure 1
siRNA mediated knockdown of robo4 and robo1. A shows RT-PCR gel for robo1 (R1), robo4 (R4) and actin (A) tran-
scripts in the presence (+) of reverse transcriptase (RT) from HUVEC total RNA. The relative expression level of robo1 has 
percentile rank of 79 ± 4.5% and robo4 is slightly higher at 83.7 ± 5.7% in HUVECs [35,36]. Numbers on the bottom of gel rep-
resent lane numbers. B depicts RT-PCR for robo1, robo4 and actin genes in the presence (+) of reverse transcriptase (RT) from 
total RNA isolated from HUVECs transfected with increasing concentrations (bars) of robo4 siRNA. For robo1 gene: lanes 4 
and 6, robo4 gene: lanes 10 and 12, and actin gene: lanes 16 and 18 represent 125 and 250 ng of siRNA respectively. Lanes 2, 8 
and 14 are RNA isolated from untransfected HUVECs, and represent endogenous levels of each transcript. C indicates the 
ratios of robo1 and robo4 transcripts by real time PCR in control lacZ siRNA and robo4 siRNA transfected cells. D shows the 
RT-PCR for robo1, robo4, and actin transcripts in robo1 siRNA (lanes 1 and 2) or control lacZ (lanes 3 and 4) siRNA cells. E 
shows western blots for V5-human Robo4 and actin protein in 293 cell lysates from samples transfected with respective siRNA 
indicated by +. F shows western blot for endogenous Robo1 and Actin protein levels in control lacZ siRNA (Cont. siRNA) or 
robo1 (R1 siRNA) and untransfected (UT) 293 cells. Lanes 1 and 3, 2 and 4 are 250 and 500 ng of respective siRNAs indicated 
on the top of the gel. Lanes 15, 17 and 19 have spillover of excess actin product in -RT lanes.BMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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Robo4 knockdown endothelial cells do not migrate to serum Figure 2
Robo4 knockdown endothelial cells do not migrate to serum. A shows the migration assay for HUVECs transfected 
with 125–750 ng of siRNA in response to fetal bovine serum (FBS, black bar) or serum free (SF) conditions. B shows migration 
assay for HUVEC transfected with control lacZ siRNA (125 ng), robo4 siRNA (125 ng), robo4 siRNA (125 ng) plus zebrafish 
Robo4 (2 μg) (zfRobo4) constructs in response to fetal bovine serum (FBS) or serum free conditions (SF). Results were 
derived from three independent experiments (n = 3) with triplicate samples each time and the data is expressed as mean +/- 
SD. Two group comparisons were determined by Student two-sample t test assuming equal variances, and statistical signifi-
cance was considered for p < 0.05. ** p < 9.83e-06 for control lacZ siRNA and R4 siRNA, and *p < 0.003 for R4 siRNA and R4 
siRNA plus zfRobo4 samples. C shows the migration assay with control lacZ or robo1 siRNA transfected endothelial cells with 
the amounts indicated on the x-axis to fetal bovine serum (FBS) or serum free conditions (SF). This experiment was repeated 
twice with triplicate sample each time. D shows migration assay with control lacZ or robo1 or robo4 siRNA transfected 
endothelial cells to VEGF (100 ng/mL). This experiment was repeated three times with duplicate sample each time. Error bars 
in C and D represent SD across three independent experiments. In panels A-D, FBS was added to the bottom well.BMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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robo4 siRNA (125–750 ng) (Fig. 2A) or control lacZ siRNA
(Fig. 2B). Wild type untransfected HUVECs showed a
robust response to serum (Fig. 2A, compare UT black and
open bars), and cells transfected with increasing concen-
trations of robo4  siRNA showed a dose dependent
decrease in migration (Fig. 2A, compare black bars 125–
750 ng). No difference in apoptosis was noted between
control lacZ and robo4 siRNA transfected cells by Annexin-
FITC assay (data not shown). Co-transfecting a zebrafish
Robo4 construct into robo4 siRNA transfected cells rescued
the migration response to serum (Fig. 2B, R4siRNA +
zfRobo4), suggesting that loss of migration phenotype
was indeed specific to Robo4. We have also performed
migration experiments with robo1 siRNA endothelial cells
to serum and observed no change in response (Fig. 2C)
when compared to lacZ siRNA cells. To determine growth
factor mediated responses to migration, we have per-
formed migration assay with vascular endothelial growth
factor (VEGF-A) on lacZ, robo1, and robo4 siRNA endothe-
lial cells and found no difference in migration across the
three samples (Fig. 2D). These results argue that a specific
stimulus (VEGF-independent) in serum triggers Robo4
but not Robo1 mediated directional migration.
The loss of migration phenotype in robo4  knockdown
endothelial cells implies that Robo1, the other endothe-
lial Robo cannot compensate for Robo4 function in
endothelial cells. We also have already shown previously
[22] that the phenotype induced by Robo1 and Robo4 on
endothelial cells are different. Robo1 induces actin fibers
that are long and thin while Robo4 induces short and
thick actin bundles along with membrane ruffles. There-
fore, it is possible that Robo1 and Robo4 serve different
functions in endothelial cells.
Slit2 binds to human endothelial cells
Human Slit2 has been previously suggested to be a ligand
for Robo4 [6,18], and is proteolytically processed into
140 kDa N-terminal and 55–60 kDa C-terminal frag-
ments in both cell culture and in vivo [13,14]. We have
performed migration assay with alkaline phosphatase
(AP)-tagged N-terminal fragment of Slit2 (AP-Slit2N),
which in the bottom chamber had previously been shown
to be the active fragment of full-length Slit2 [13]. Migra-
tion of control lacZ siRNA transfected cells is inhibited by
AP-Slit2N while migration of robo4 siRNA cells is not (Fig.
3A). To determine if Slit2 binding is altered in robo4
siRNA transfected cells, we have performed biochemical-
binding analysis taking advantage of AP-tag on Slit2. AP-
Slit2N was incubated with control lacZ or robo4 siRNA
transfected endothelial cells, and bound Slit2 was
detected by AP activity in the lysate. AP activity was higher
in control lacZ  siRNA than robo4  siRNA transfected
endothelial cells suggesting that the presence of Robo4
facilitates Slit2 interaction on endothelial cells (Fig. 3B).
Slit2 also interacts with Robo1 and this interaction occurs
via the immunoglobulin (IgG) domains in Robo1 and the
second leucine rich repeat sequence in Slit2 [19]. The Kd
of the Slit2-Robo1 interaction is reported to be 8–10 nM
[19,26] and since the IgG domain is conserved in Robo1
and Robo4, we predict similar Kd's for Slit2-Robo4 inter-
action. The migration and biochemical binding analysis
data taken together suggest that Slit2 binds to endothelial
cells expressing Robo1 and Robo4 and inhibits their
migration.
Slit2 shows both chemotactic and chemokinetic effects on 
endothelial cells and the chemotactic response is in part 
through Robo4
Robo4 siRNA transfected cells did not respond to serum
(Figs. 2A and 2B) but, remarkably, show a three-fold
increase in migration to a Slit2 gradient when compared
to control lacZ siRNA cells (Fig. 3A, black bars). Similar
results are observed in mouse robo4 knockout cells. Mouse
robo4 knockout endothelial cells migrate to VEGF-A better
than control cells [7]. These results argue that irrespective
of the stimulus, VEGF or Slit2, robo4  siRNA or robo4
knockout endothelial cells show a pro-migratory
response.
To investigate why robo4 knockdown cells migrate to a
Slit2 gradient, we have determined whether the migration
response was chemotactic or chemokinetic. Chemotaxis is
referred to directional movement towards or away from a
gradient while chemokinesis is a cellular response associ-
ated to speeding up or slowing down movement and is
gradient independent [27]. To differentiate between the
two types of migration, we have performed the Boyden
chamber assay with control lacZ siRNA and robo4 siRNA
transfected cells to serum or Slit2. Previous reports of Slit2
on leukocyte migration clearly showed that irrespective of
where Slit2 was present, upper, lower or both chambers,
Slit2 inhibited SDF-1α induced leukocyte migration argu-
ing for a chemokinetic and chemotactic inhibitory activity
for Slit2 in this system [28]. Therefore, we hypothesized
that Slit2 behaves similarly in endothelial cell migration.
Slit2 in the upper, lower or both chambers showed similar
increased motility of robo4 siRNA cells relative to that of
control lacZ siRNA cells (Fig. 3C, Slit2 bars). Therefore,
the positive response to Slit2 is chemokinetic. In contrast,
serum stimulated only chemotactic motility of control
cells. Chemotaxis to serum was blocked in robo4 siRNA
cells (Fig. 3C, FBS bars), and this blockade was only
detected when serum was in the bottom chamber. The
serum response of robo4  knockdown cells therefore
excludes the possibility that robo4  knockdown cells by
themselves display random movement. The Slit response
on the other hand is a combination of chemotaxis and
chemokinesis. Therefore, our data indicate that Slit2BMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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shows both chemotactic and chemokinetic effects on
endothelial cells, and the chemotactic response is in part
through Robo4 while serum mediates an exclusive chem-
otactic response on robo4 knockdown endothelial cells.
Mechanism of Slit2 inhibition of endothelial migration is 
independent of the Rho GTPase pathway
Previously, we had shown that Rho GTPases were acti-
vated by Robo4 in endothelial cells [22]. To investigate
whether active Rho GTPases are modulated by Slit2 treat-
ment of endothelial cells, we have checked by pulldown
assay for Cdc42-GTP levels in control endothelial cells.
Slit2 was incubated for 5, 10 (data not shown) and 15 min
with control endothelial cells and pulldown analysis was
performed on lysates from the treated cells (Fig. 3D). We
did not convincingly notice an up-regulation of Cdc42-
GTP levels in endothelial cells treated with Slit2 in either
5 or 15 min incubation times. (Fig. 3D, compare lanes 1
Slit2 mediates chemokinetic and chemotactic behaviour on endothelial cells while serum exclusively mediates chemotaxis Figure 3
Slit2 mediates chemokinetic and chemotactic behaviour on endothelial cells while serum exclusively mediates 
chemotaxis. A shows the migration of control lacZ siRNA and robo4 siRNA transfected endothelial cells to AP and AP-Slit2N 
(25 ng/ml) fusion proteins in a Boyden chamber assay. The data here is consolidated from three independent experiments with 
each experiment performed with samples in triplicate. B shows the AP activity in lysates prepared from untransfected (UT), 
AP and AP-Slit2N treated control and robo4 siRNA transfected endothelial cells. C shows migration assay for control lacZ and 
robo4 siRNA transfected cells to Serum or AP-Slit2N in either upper (U), lower (L) or both chambers as indicated. Error bars 
in A (n = 3), and B (n = 3) represent SD while in C represent SEM (n = 4). D shows pulldown analysis of Cdc42-GTP levels in 
AP and AP-Slit2N (25 ng/ml) treated endothelial cell lysates for 5 and 15 minute respectively. + indicate addition of the reagent 
on the left, pd: pulldown, total: total Cdc42 protein in lysates.BMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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& 3 with 2 & 4 respectively). Since Slit2 treated endothe-
lial cells do not migrate and show no activation of Rho
GTPases, the mechanism of Slit2 inhibition of endothelial
migration is most likely independent of the Rho GTPase
pathway. It is important to note that our data supports the
conclusions of Park [6] and Seth [18]et al., that Slit2
inhibits migration of endothelial cells. However, removal
of Robo4 alters the Slit2 response dramatically in that the
cells move independent of the Slit gradient. This data can
also be interpreted as the "removal of the brake" scenario
where once the cellular brake is removed the cells begin to
move randomly to Slit2 but not to serum suggesting the
presence of an as yet unidentified ligand to Robo4 in
serum that mediates a specific chemotactic positive
response via Robo4. The mouse robo4 knockout endothe-
lial cell when compared to mouse wild-type lung microv-
ascular endothelial cell also show a similar pro-migratory
response to VEGF-A [7] and therefore suggests a common
chemokinetic response to single growth factors by robo4
loss-of-function endothelial cells.
Vilse, a Cdc42-GAP interacts with Robo4 cytoplasmic tail
Robo4 over-expressing endothelial cells show high levels
of Cdc42-GTP and Rac-GTP [22] proteins. Whether the
Cdc42-GTP up-regulation was a result of a guanine
exchange factor (GEF) up-regulation or a GTPase activat-
ing protein (GAP) sequestering was not known. We made
an educated guess on Vilse (Cdc42-GAP), since Vilse inter-
acts with the intracellular CC2 domain in Robo1 that is
shared by Robo4 as well [29]. Vilse indeed interacts with
Robo4 cytoplasmic tail (Fig. 4A, lane 3) at least in
HEK293T cells. Following Slit2 treatment, a slight increase
in Robo4 pulldown levels is noticed (Fig. 4A, lane 4) but
this increase is not observed in a consistent basis and
therefore Vilse's interaction and its role in Slit2-Robo4 sig-
naling is not clear. However, since serum was present in
the pull-down assays, it is conceivable that Vilse interac-
tion to Robo4 cytoplasmic tail is triggered by serum.
Therefore, it is possible that serum mediated recruitment
of Vilse, a Cdc42-GAP to Robo4 cytoplasmic tail is respon-
sible for Rho GTPase activation. In terms of Slit2, we
hypothesize that Rho GTPase independent mechanisms
are in play for Slit2 inhibition of endothelial cell migra-
tion.
Robo1 and Robo4 interact in vitro
Robo1 and Robo4 share two common features in that
they bind Slit2 extracellularly and interact with Vilse intra-
cellularly. Since Robos are known to homo- or hetero-
dimerize [11], we investigated if Robo1 and Robo4 inter-
act with each other by immunoprecipitation (IP) and
western blot (Fig. 4B). In one set of experiments, we trans-
fected HA-tagged rat Robo1 and V5-tagged human Robo4
(Fig. 4B, left panel), while in a second set of experiments,
we transfected HA-tagged rat Robo1 construct and mouse
Robo4 constructs (Fig. 4B, right panel) into HEK293T
cells either alone or together. IP with V5 antibody (Fig. 4B,
IP: V5, left panel) brought down Robo1 (Fig. 4B, left
panel, last lane, top HA blot). Conversely, IP with HA
antibody (Fig. 4B, IP: HA, right panel) resulted in pull
down of mouse Robo4 (Fig. 4B, right panel, last lane, top
mR4 blot). This data suggests that both mouse and
human Robo4 interact with rat Robo1 and that similar to
neuronal Robos, vascular Robos also interact.
Rho GTPase homeostasis is essential for Robo4-induced 
migration
To investigate the active Cdc42 and Rac levels in robo4
knockdown cells, we have performed biochemical pull
down analysis for Cdc42-GTP and Rac-GTP in the robo4
knockdown endothelial cells. Unexpectedly, the knock-
down cells showed increased levels of Cdc42 and Rac-GTP
(Fig. 4C, lane 2), which return to baseline in cells trans-
fected with zebrafish Robo4 (Fig. 4C, lane 3). When com-
bined with migration rescue experiment (Fig. 2B,
R4siRNA + zfRobo4 black bar), this result suggests that
restoring the balance of active vs. inactive Rho GTPases in
an endothelial cell is required for chemotaxis. It is also
worth noting that the previously published pull down
data showed lower amounts of active Cdc42 and Rac in
robo4  knockdown embryos [22], which was performed
from whole embryo lysates and not from endothelial cells
in the embryo.
Although robo4 knockdown endothelial cells contain high
levels of Cdc42-GTP (Fig. 4C, lane 2), they do not migrate
to serum (Fig. 2A). This result suggests that Cdc42-GTP
level alone is not enough for directional migration but the
interaction of active Cdc42 presumably with other pro-
teins involved in filopodia formation or migration is
important for this function. One such protein previously
implicated in Cdc42-GTP induced filopodia formation is
insulin receptor substrate protein 53 (IRSp53), a SH3
domain-containing adaptor molecule. IRSp53 protein
interacts with Cdc42-GTP to promote filopodia formation
in COS or Swiss 3T3 cells via an IRSp53 effector protein
Mena, an Ena/VASP family member [30]. It is known that
interaction of Cdc42 with the CRIB motif of IRSp53
relieves an intramolecular autoinhibitory interaction with
the N terminus, allowing the recruitment of Mena to the
IRSp53 SH3 domain [30]. The IRSp53:Mena complex ini-
tiates actin filament assembly into filopodia. Since Robo4
interacts with Mena [6], we asked whether IRSp53 pro-
tein, a target of active Cdc42 was involved in Robo4 sign-
aling in endothelial cells. In robo4 knockdown endothelial
cells co-transfected with myc-IRSp53 construct (Fig. 4D,
lane R4), we noticed that the IRSp53 protein levels were
lower when compared to samples of control lacZ siRNA
transfected cells with myc-IRSp53 (Fig. 4D, lane Con). We
have stained for F-actin phalloidin in robo4 siRNA (Fig.BMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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Vilse and Robo1 interact with Robo4 and Rho GTPase homeostasis is important for Robo4 mediated directional migration Figure 4
Vilse and Robo1 interact with Robo4 and Rho GTPase homeostasis is important for Robo4 mediated direc-
tional migration. A shows the interaction between Robo4 and Vilse in 293 cells. Myc-Vilse and V5-tagged human Robo4 
were co-transfected into 293 cells in different combinations as indicated by + and -. Slit2N was added to the transfected cells 
and lysates were immunoprecipitated by myc antibody followed by western with V5 antibody. B shows IP/Western analysis for 
rat Robo1 and human Robo4 (left panel) or rat Robo1 and mouse Robo4 (right panel). The antibodies are indicated to the left 
and right of the gels. Tub: tubulin, mR4: mouse Robo4. The top gel in each panel represents the IP'd lysate western blotted 
with the indicated antibody. The rest of the gels are western blots for the respective proteins either present (+) or absent (-) 
as indicated for each sample in the top of the gel. C shows pull down analysis for Cdc42-GTP and Rac-GTP in Con (control) 
siRNA, robo4 (R4) siRNA and robo4 siRNA plus zfRobo4 transfected endothelial cells. Quantitation of the western blots was 
performed as described before [22]. Antibodies used for westerns are shown to the left of the blot. D shows western blots 
with myc and actin antibody of lysates from control lacZ siRNA (lane 1) or robo4 siRNA (lane 2) co-transfected with myc-
IRSp53 constructs in endothelial cells. E and F are confocal images of F-actin phalloidin (red) stained endothelial cells trans-
fected with reagents shown below the panel. Slides were mounted in media containing DAPI (blue), which stains nuclei. For A, 
B, C and D + indicates addition of the reagent on the left, IP-immunoprecipitation, WB-western blot, antibodies indicated on 
right, For panels C, D, E and F Con: control lacZ siRNA, R4: robo4 siRNA.BMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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4E) and control lacZ  siRNA (Fig. 4F) cells and clearly
noticed a loss of organized actin stress fibers in robo4
siRNA transfected cells. So, taking the IRSp53 stability
(Fig. 4D), actin phalloidin staining (Figs. 4E and 4F) and
activated Rho GTPase in robo4 knockdown cell (Fig. 4C)
data together, a strong correlative argument can be made
that in the absence of Robo4, IRSp53 is unavailable for
active Cdc42-GTP interaction resulting in blocking of
downstream events that lead to actin nucleation and filo-
podia formation. Further, the zebrafish Robo4 co-trans-
fected sample (Fig. 4C, lane 3) shows Rho GTPase levels
comparable to baseline thus allowing for endothelial cell
chemotaxis to serum (Fig. 2B). This data also suggests that
stabilization of IRSp53 protein may allow for excess
Cdc42-GTP to be used for actin nucleation, and that a one
to one correlation between IRSp53 and Cdc42-GTP mole-
cules in a given cell may dictate the actin nucleation and
filopodia formation process.
Proposed mechanism of Robo4 function in endothelial cell 
migration
Taking all the results in this study together, we propose a
working model (Fig. 5) that is built on previous models
[10]. In this model, we will integrate the following mole-
cules: Robo1, Robo4, Slit2, Non-Slit ligand, Cdc42-GTP,
IRSp53, Vilse and Mena. Here, two assumptions are in
place: (1) Slit mediated migration is chemotactic and
chemokinetic in nature while serum (non-Slit) mediated
migration is exclusively chemotactic in nature, (2) Signal-
ing outputs of ligand-receptor complex is context depend-
ent and active switching between Robo1 and Robo4 at cell
surface dictates directional migration of endothelial cell.
In situation when chemokinesis and chemotaxis are
required concomitantly such as wound healing, the Slit
pathway is active. In the resting state i.e., in the absence of
Slit, cell surface Robos physically interact with each other,
which may keep both Robos in an inactive state. Another
possibility is that only one Robo is expressed at any given
time on the cell surface and acts singularly since we know
that Robo levels on the cell surface are tightly regulated.
Therefore, the physical interaction is a safety mechanism
of aberrantly activating Robos on cell surface. Slit binds to
Robo1 and Robo4, and it is not clear if this interaction is
dependent on the presence of the other Robo. Two conse-
quences can be predicted: (a) a direct negative stimulus
emanates from Robo1 or (b) the positive stimulus from
Robo4 is blocked. Both the predictions involve a Rho
GTPase independent mechanism in down stream signal-
ing events. The net output is migration of the endothelial
cell forward or away from the target site.
In situation where you require exclusive chemotaxis such
as during development of ISVs during embryonic devel-
Model depicting Robo1 and Robo4 mechanism of action in endothelial cell guidance Figure 5
Model depicting Robo1 and Robo4 mechanism of action in endothelial cell guidance. Cell A: In resting state, in the 
absence of ligand (serum or Slit2), Robo1 and Robo4 interact and stay in an inactive conformation. On ligand binding, Vilse, a 
Cdc42-GAP is recruited to CC2 domain of Robo1 and Robo4 resulting in an increase in intracellular Cdc42-GTP levels. The 
Cdc42-GTP binds to CRIB domain in IRSp53, which changes conformation of IRSp53 from inactive to active state. The active 
conformation of IRSp53 allows Mena to interact with the exposed SH3 domain of IRSp53. Cell B: In an activated state, Mena 
recruits the complex to CC2 domain of Robo4's cytoplasmic tail or directly mediates actin nucleation resulting in filopodia for-
mation and directional migration. This cartoon is a working model and is not conclusive.BMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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opment, a non-Slit pathway is active. Again, in the resting
state Robo cell surface levels are tightly regulated by one
of three ways: (1) physical interaction between the two
Robos or, (2) one Robo is selectively down-regulated or,
(3) only the particular Robo of relevance is expressed on
the cell of interest in this case the tip cell. To continue a
directional path for the tip cell such as along the chevron
of the somite, a non-Slit ligand binds to Robo4 resulting
in recruitment of Vilse, the net result is activation of
Cdc42. The activated Cdc42 interacts with the stabilized
IRSp53 in the endothelial tip cell allowing the SH3
domain of IRSp53 to interact with Mena (Fig. 5). This
complex of Cdc42-GTP-IRSp53-Mena results in actin
cytoskeleton rearrangement leading to filopodia forma-
tion and migration.
Robo4 function in tip and stalk cells
Robos were originally identified as axon guidance mole-
cules and therefore a vascular Robo, Robo1 or Robo4 was
expected to function in a growth cone analogous structure
in endothelial cells namely tip cells. The retinal vascular
bed has been shown to contain two distinct cell types in
the developing vasculature namely the tip cell and the fol-
lowing stalk cell [31]. In the retinal vasculature, it was
shown that tip cells do not proliferate but merely guide
the following proliferative stalk cell by a VEGF-dependant
process. The combined tip and stalk cell activity is thought
to extend the developing endothelial sprouts. Recent evi-
dence in zebrafish has challenged the notion that tip cells
don't proliferate [32] since zebrafish trunk ISV tip cells do.
This result argues that tip cells function is tissue depend-
ant. In zebrafish, we have noted that robo4 is expressed
along the entire length of the intersomitic sprout compris-
ing of both the tip and stalk cell [5], and functions in a
manner that is anticipated for axon guidance molecules in
that  robo4  knockdown embryos display ISV defects.
Whether proliferation of ISV cells has altered in robo4
knockdown embryos is not known and is being investi-
gated. Recent result of robo4 expression in mouse stalk cell
[7] raises the issue whether higher vertebrates, in particu-
lar mammals have adapted Robos for other functions
besides guidance. This is particularly possible given the
fact that Robo4AP/AP mouse did not show developmental
vascular defects in the ISVs or cephalic vessels [7]. Other
reasons include, Robo4 stalk and tip cell function are spe-
cies specific, vascular permeability is different in mouse
and zebrafish. In the Robo4AP/AP mouse it was shown that
Slit2-Robo4 signaling intercepted the VEGF permeability-
signaling axis and is conceivable that the Robo4-stalk cell-
permeability function is Slit dependant while the Robo4-
tip cell-guidance function is non-Slit dependant. The in
vivo expression pattern of Slits in zebrafish [33,34] and
our data in this study that shows serum mediates positive
chemotactic response via Robo4 provides supporting evi-
dence for the latter.
This study raises numerous questions. What mechanisms
are in play for a cell to recognize when to invoke chemo-
taxis vs. chemokinesis pathways? The fine details of the
model proposed here (Fig. 5) raise several questions. Is
Mena released from Robo4 cytoplasmic tail on ligand
binding? What is the ligand that mediates this action?
What is the order of Mena and Vilse recruitment to the
Robo4 cytoplasmic tail? Does IRSp53 protein stability
control the levels of active Cdc42-GTP in endothelial
cells? How do these complexes promote filopodia forma-
tion in endothelial cells? These and other issues form the
basis of future work in the laboratory.
Conclusion
Our data suggests that endothelial cells utilize Robos in a
context dependant manner and signals from surrounding
milieu [Serum (non-Slit) vs. Slit2] dictate different
responses and perhaps signals in endothelial cells.
Methods
RNA isolation, RT-PCR, Real Time PCR and Reagents
Total RNA was isolated from HUVECs 48 h post transfec-
tion by the Trizol method. RT-PCR was performed by
using primer pairs described previously for hRobo1 [8]; β-
actin [8], and hRobo4 [18]. Real time PCR Primers for
hRobo1: F: CCTTCCACCAGCAAAGACTC, R: TGAG-
GAACTGGGATCTCTGG; hRobo4: F: GCAGTCACTGGT-
GCTGGAG; R: GACCATGCTCACTGGGTTCT; and β-
actin: F: GGCATCCTCACCCTGAAGTA, R: AGGTGTGGT-
GCCAGATTTTC. The vector pAP-Slit2N was obtained
from Dr. Alain Chédotal (Université Paris). Myc-IRSp53
and myc-Vilse constructs were gifts from Dr. Alan Hall
(Sloan Kettering Institute) and Dr. Greg Bashaw (Univer-
sity of Pennsylvania) respectively. Mouse Robo4 construct
and mouse Robo4 antibody were gifts from Dr. Dean Y Li
(University of Utah).
Dicer RNA knockdown
The human robo4 region corresponding from 1324 bp to
1732 bp was amplified using primers F: GCTGCAGT-
CACTGGTGCTGGAGCTGG and R: GGTCCCGGGCATC-
CGCCCCCAGCCG. The human robo1  region
corresponding from 127 bp to 579 bp was amplified
using primers F: TAATACGACTCACTATAGGGCCAATC-
CCCACCTCTGATAA and R: ATTAACCCTCACTAAAG-
GGAGGTTGGCATTCCATTACTGC. SiRNA was generated
according to BLOCK-iTTM Complete Dicer RNAi Kit (Inv-
itrogen) recommendations. HUVEC cells were grown to
80% confluence and transfected with 125, 250, 750 and
1000 ng of siRNA per well by LipofectamineTM 2000 Rea-
gent. For robo1 siRNA experiments, 250 and 500 ng were
used and for control lacZ siRNA comparable doses were
used. For rescue experiments, zebrafish Robo4 described
previously [22] was used. We performed endothelial cellBMC Cell Biology 2008, 9:61 http://www.biomedcentral.com/1471-2121/9/61
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transfection with either the Lipofectamine 2000 reagent
or the Magnetofection method.
Rho GTPase pull down and Western Blot assays
Pull down assays were performed as previously described
[22] with a modification that endothelial lysates were
generated 24 h post transfection. For Fig. 2D, HUVECs
were serum starved for 12 h prior to treatment with AP-
Slit2N (40 ng/ml) for the indicated times. Lysates were
generated from treated samples using buffer provided by
the Pierce Cdc42 pull down assay kit. For determining
Robo4 protein levels of knockdown experiments (Fig.
1E), western blots were performed on lysates from co-
transfected samples containing V5-tag human Robo4 and
control or robo4 siRNA. Lysates were also probed for actin
(Sigma). For co-IP experiments in HEK293T cells, equal
amounts of the two plasmids (5 μg) were either co-trans-
fected or not depending on the combination desired for
36 h. Lysates were made in RIPA buffer (Sigma) and pre-
cleared with protein G-agarose (Pierce) for 3 h. Precleared
lysates were IP'd with myc antibody (1:1000) (Cell Sign-
aling) for overnight. The myc antibody was captured by
protein G-agarose for 3 h. All IP steps were performed at
4°C. The beads were washed three times with RIPA buffer
and 2× sample buffer was added prior to boiling. The
heated samples were resolved on 7% SDS-PAGE (Novex)
and western blot was performed as described previously
[22]. In case of Slit2 treated samples, 40 ng/ml of AP-
Slit2N was incubated with co-transfected cells for 1 h. Five
micrograms of myc-tagged IRSp53 was co-transfected into
robo4  siRNA (250 ng) or control lacZ  siRNA (250 ng)
endothelial cells by Lipofectamine 2000 reagent. Twenty-
four hours post transfection lysates were made as
described earlier. Quantitation of western blots were per-
formed as described before [22].
AP fusion protein generation, AP activity assays
For AP fusion proteins, HEK293T cells were transfected
with pAP-tag5 and pAP-Slit2N constructs. Forty-eight
hours post transfection; supernatant was collected by cen-
trifugation to remove cell debris. All assays with AP pro-
teins used HEK293T supernatants directly without further
purification. AP controls processed in an identical manner
were used as controls. AP binding assay was performed by
incubation of equal amounts of AP and AP-Slit2N pro-
teins (25 ng/mL) with control or robo4 siRNA cells for 1 h
at 4°C. Cells were washed three time with 1× PBS and
lysates were made with AP lysis buffer (GenHunter). The
lysates were heat inactivated at 65°C for 10 min to inacti-
vate background phosphatase activity and protein con-
centration was measured using bicinchoninic acid (BCA)
assay (Pierce). Equal amounts of protein were used for
detecting AP activity. AP activity was measured by adding
AP assay reagent A (GenHunter) and absorbance read at
405 nm using a microplate reader.
Migration assay
Migration assay was performed as described before [22].
All migration assays were performed with HUVECs pas-
sage 2–4. Briefly, 20,000 cells from each experimental
group were placed in the upper chamber in a final volume
of 350 μL of serum free medium. Serum (10% FBS) or
VEGF-A (100 ng/mL in serum free medium) was placed in
the bottom chamber in a final volume of 500 μL. All
migration assays were conducted for 5 h at 37°C and at
the end of the assay the cells were fixed and counted as per
the manufacturer's instructions (Dade Behring). For dif-
ferentiating between chemokinesis and chemotaxis, a
checkerboard format of adding Slit2 or serum to upper,
lower or both chambers was performed.
Confocal immunofluorescent microscopy
HUVEC cells were grown on cover slips, fixed with 4% for-
maldehyde in PBS for 1 h at room temperature, and per-
meabilized for 30 min with 0.1% Triton X-100 in PBS
containing 1% BSA. Cells were incubated for 20 min with
phalloidin conjugated to Texas Red (Molecular Probes,
Inc.), and cover slips were mounted in DAPI media for
confocal imaging using a Zeiss LSM510 confocal system
mounted on a Zeiss Axiovert 100 M microscope.
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